📰 Cell Based Flu News
Cell Based Flu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Based Flu. Real-time updates on events, politics, business and more.
February 25, 2022
/PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced the renewal of a five-year agreement...
February 25, 2022
/PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced the renewal of a five-year agreement...
February 7, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
November 23, 2021
/PRNewswire/ -- The FDA has granted approval of multi-dose vial presentation for AUDENZ™ to help protect individuals six months of age and older against...
October 19, 2021
/PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced new real-world evidence (RWE)...
October 15, 2021
/PRNewswire/ -- Seqirus, a global leader in influenza prevention, and a business of CSL Limited (ASX: CSL), today announced that the U.S. Food and Drug...
October 14, 2021
/PRNewswire/ -- Seqirus, a global leader in influenza prevention, and a business of CSL Limited (ASX:CSL), today announced that The New England Journal of...
October 14, 2021
/PRNewswire/ -- Seqirus, a global leader in influenza prevention, and a business of CSL Limited (ASX:CSL), today announced that The New England Journal of...
October 5, 2021
/PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced that the Biomedical Advanced Research...
May 3, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation. Seqirus Presents New Phase 3 Clinical Data Supporting Use of Cell-Based Seasonal Influenza Vaccine in Children Six Months Through